BIO announced plenary sessions, Business Roundtables, and Therapeutic Workshops selected for 16th annual BIO CEO & Investor Conference. Scheduled for Feb 10–11, conference will feature biotech, pharma, and Wall Street leaders sharing their candid insights on what to expect in 2014 and beyond. Plenary Sessions will address upcoming year, using results of joint BIO/ISI published Buy-Side Perception Study, as well as dissect new capital market environment’s impact on fundraising.
This story is related to the following:Trade Associations